Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Jounce Therapeutics, Inc. (JNCE) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/15/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
05/05/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/04/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/04/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/04/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/04/2023 8-K Quarterly results
05/04/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/04/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/28/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/25/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/24/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/06/2023 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
04/06/2023 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
04/03/2023 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
03/28/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/27/2023 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
03/27/2023 8-K Acquisition/merger/asset purchase announced
Docs: "AGREEMENT AND PLAN OF MERGER",
"NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH"
03/17/2023 SC 13D/A TANG CAPITAL PARTNERS LP reports a 10.2% stake in Jounce Therapeutics, Inc.
03/15/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/15/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Jounce Therapeutics Confirms Receipt of Unsolicited Proposal from Concentra Biosciences"
03/14/2023 SC 13D TANG CAPITAL PARTNERS LP reports a 10.2% stake in Jounce Therapeutics, Inc.
03/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/10/2023 10-K Annual Report for the period ended December 31, 2022
03/06/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 9.7% stake in Jounce Therapeutics, Inc.
02/23/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy